VR Adviser as of Sept. 30, 2024
Portfolio Holdings for VR Adviser
VR Adviser holds 38 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 26.1 | $499M | 8.5M | 58.74 | |
| Ocular Therapeutix (OCUL) | 5.8 | $111M | 13M | 8.70 | |
| Enliven Therapeutics (ELVN) | 5.4 | $103M | 4.0M | 25.54 | |
| Miragen Therapeutics (VRDN) | 4.6 | $88M | 3.9M | 22.75 | |
| Applied Therapeutics (APLT) | 4.4 | $84M | 9.8M | 8.50 | |
| Spyre Therapeutics Com New (SYRE) | 4.1 | $79M | 2.7M | 29.41 | |
| Dyne Therapeutics (DYN) | 4.1 | $78M | 2.2M | 35.92 | |
| Oruka Therapeutics | 4.0 | $76M | 3.1M | 24.51 | |
| Kalvista Pharmaceuticals (KALV) | 3.8 | $72M | 6.2M | 11.58 | |
| Pharvaris N V (PHVS) | 3.3 | $63M | 3.4M | 18.52 | |
| Cogent Biosciences (COGT) | 3.2 | $61M | 5.7M | 10.80 | |
| Dianthus Therapeutics (DNTH) | 2.5 | $48M | 1.7M | 27.38 | |
| 4d Molecular Therapeutics In (FDMT) | 2.5 | $48M | 4.4M | 10.81 | |
| Merus N V (MRUS) | 2.4 | $45M | 908k | 49.96 | |
| Oric Pharmaceuticals (ORIC) | 2.4 | $45M | 4.4M | 10.25 | |
| Erasca (ERAS) | 2.3 | $44M | 16M | 2.73 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.1 | $41M | 706k | 57.54 | |
| Astria Therapeutics (ATXS) | 2.0 | $38M | 3.5M | 11.01 | |
| Terns Pharmaceuticals (TERN) | 1.5 | $28M | 3.4M | 8.34 | |
| Aquestive Therapeutics (AQST) | 1.4 | $28M | 5.6M | 4.98 | |
| Edgewise Therapeutics (EWTX) | 1.4 | $27M | 1.0M | 26.69 | |
| Artiva Biotherapeutics | 1.3 | $25M | 1.6M | 15.45 | |
| Engene Holdings (ENGN) | 1.2 | $24M | 3.6M | 6.60 | |
| Cullinan Oncology (CGEM) | 1.2 | $23M | 1.4M | 16.74 | |
| Mersana Therapeutics (MRSN) | 1.1 | $21M | 11M | 1.89 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.9 | $18M | 9.0M | 2.01 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.8 | $16M | 1.3M | 11.52 | |
| Trevi Therapeutics (TRVI) | 0.6 | $11M | 3.4M | 3.34 | |
| Arvinas Ord (ARVN) | 0.6 | $11M | 455k | 24.63 | |
| Adverum Biotechnologies Com New (ADVM) | 0.5 | $10M | 1.5M | 7.02 | |
| Century Therapeutics (IPSC) | 0.5 | $9.2M | 5.4M | 1.71 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.4 | $8.2M | 2.0M | 4.06 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.4 | $7.5M | 750k | 10.02 | |
| Cabaletta Bio (CABA) | 0.4 | $7.4M | 1.6M | 4.72 | |
| Casi Pharmaceuticals Ord Shs (CASI) | 0.3 | $6.1M | 987k | 6.16 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $3.0M | 1.6M | 1.93 | |
| Instil Bio Com New (TIL) | 0.1 | $2.2M | 33k | 67.32 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $721k | 208k | 3.46 |
